CAR T-Cell Therapy for Children with Relapsed ALL

CAR T-cell therapy is an FDA-approved treatment for patients who are up to 25 years old with second or later relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). Dana-Farber/Boston Children’s Cancer and Blood Disorders Center is a certified treatment center offering this new therapy.

Learn more about CAR T-cell therapy: http://www.danafarberbostonchi....ldrens.org/car-t-cel